Publicacións en colaboración con investigadores/as de Hospital Universitario Virgen Macarena (8)

2024

  1. Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeability conditions

    International Journal of Antimicrobial Agents, Vol. 63, Núm. 5

  2. Corrigendum to “Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeability conditions” [International Journal of Antimicrobial Agents Volume 63, Issue 5 (2024) 107150] (International Journal of Antimicrobial Agents (2024) 63(5), (S0924857924000682), (10.1016/j.ijantimicag.2024.107150))

    International Journal of Antimicrobial Agents

2010

  1. Clinical features of infections and colonization by Acinetobacter genospecies 3

    Journal of Clinical Microbiology, Vol. 48, Núm. 12, pp. 4623-4626

2009

  1. Genetic variability among ampC genes from Acinetobacter genomic species 3

    Antimicrobial Agents and Chemotherapy, Vol. 53, Núm. 3, pp. 1177-1184

2008

  1. False extended-spectrum β-lactamase detection in Acinetobacter spp. due to intrinsic susceptibility to clavulanic acid

    Journal of Antimicrobial Chemotherapy, Vol. 61, Núm. 2, pp. 301-308

2004

  1. Antimicrobial Susceptibility and Mechanisms of Resistance to Quinolones and β-Lactams in Acinetobacter Genospecies 3

    Antimicrobial Agents and Chemotherapy, Vol. 48, Núm. 4, pp. 1430-1432

  2. Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals

    Infection Control and Hospital Epidemiology, Vol. 25, Núm. 10, pp. 819-824

  3. Type 1 Integrons in Epidemiologically Unrelated Acinetobacter baumannii Isolates Collected at Spanish Hospitals [3]

    Antimicrobial Agents and Chemotherapy